Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Compound traditional Chinese medicine for improving eyesight and its prepn. method

A technology for compound preparations and traditional Chinese medicines, which can be used in pharmaceutical formulations, medical preparations containing active ingredients, and pill delivery, etc.

Active Publication Date: 2008-10-29
YANGTZE RIVER PHARMA GRP JIA NGSU LONGFENGTANG TRADITIONAL CHINESE MEDICINE CO LTD +1
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are not many drugs for the clinical treatment of central serous chorioretinopathy, which only belong to symptomatic treatment, and the curative effect is not satisfactory.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] The preparation of embodiment one Chinese medicine syrup a of the present invention

[0037] (1) The following weight ratio takes each component:

[0038] Cassia seed 264g Polygonum multiflorum 220g Mother of pearl 528g

[0039] Chrysanthemum 132g Prunella vulgaris 220g Angelica 220g

[0040] Paeoniae Alba 220g Lycium barbarum 220g Radix Paeoniae Rubra 220g

[0041] Safflower 220g Motherwort 330g Plantago Seed 220g

[0042] Poria cocos 220g, winter melon seeds 330g, licorice 66g.

[0043] (2) The above-mentioned weight ratio depends on the five flavors of Semen Cassiae, Radix Polygoni Multiflori, Fructus Lycium Barbarum, Poria Cocos and Fructus Plantaginis beaten into coarse powder, percolated with 70% ethanol, and the percolated liquid is collected;

[0044] (3) According to the above weight ratio, boil mother-of-pearl with water for 1 hour, add the remaining nine flavors and boil twice, the first time for 1.5 hours, the second time for 1 hour, filter, combine the ...

Embodiment 2

[0046] The preparation of embodiment two Chinese medicine syrup b of the present invention

[0047] (1) The following weight ratio takes each component:

[0048] Cassia seed 397g Polygonum multiflorum 330g Mother of pearl 792g

[0049] Chrysanthemum 198g Prunella vulgaris 330g Angelica 330g

[0050] White peony 330g Goji berries 330g Red peony 330g

[0051] Safflower 330g Motherwort 495g Plantago 330g

[0052] Poria cocos 330g, winter melon seeds 496g, licorice 99g.

[0053] (2) The above-mentioned weight ratio depends on the five flavors of cassia seed, Polygonum multiflorum multiflorum, Fructus Lycium barbarum, Poria cocos and Fructus Plantaginis beaten into coarse powder, percolated with 60% ethanol, and the percolated liquid is collected.

[0054](3) According to the above weight ratio, boil the remaining ten flavors three times, each time for 1 hour, filter, combine the medicinal liquid, concentrate the filtrate to an appropriate amount, add ethanol to make the alcoho...

Embodiment 3

[0056] The animal long-term toxicity experiment of embodiment three syrup preparation a of the present invention

[0057] Syrup a of the present invention is orally administered to rats for three months as a chronic test result and shows: the body weight growth percentages of the large and medium dose groups are lower than those of the control group and the small dose group, and the BUN of the large dose group has a tendency to increase, and there is no significant change in statistical inspection. The white blood cells in the high-dose group tended to decrease, but their values ​​were still within the normal range. According to the case examination, there were 2 cases of mild fatty degeneration of liver cells in the high-dose group, suggesting that the use of high-dose may cause mild lipid metabolism disorder in the liver, indicating that high-dose has certain toxic effects on animals, so the clinical dosage should be controlled, but only On the whole of the test, the syrup a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A Chinese medicine for improving acuity of vision is prepared from 15 Chinese-medicinal materials including cassia seed, fleece flower root, nacre, chrysanthemum flower, etc through proportional mixing, extracting in water or alcohol, and shaping.

Description

Technical field [0001] The invention relates to a Chinese medicine compound preparation for improving eyesight, including the composition of the Chinese medicine preparation and a preparation method thereof. Background technique [0002] Central serous retinochoroidopathy is one of the common clinical internal eye diseases. The lesion is located in the macular area of ​​the retina, which seriously affects vision and is accompanied by metamorphopsia, eyeball pain, and shadows in front of the eyes. It is of special significance clinically. At present, there are not many drugs for the clinical treatment of central serous chorioretinopathy, which only belong to symptomatic treatment, and the curative effect is not satisfactory. Chinese patent medicines have not been seen yet. Contents of the invention [0003] The present invention comprehensively analyzes the symptoms and pathological changes of central serous chorioretinopathy, because its pathogenesis is mainly liver and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/815A61K36/71A61K36/704A61K36/68A61K36/536A61K36/533A61K36/484A61K35/56A61K9/20A61P27/02A61K35/618
Inventor 陆宏国张玉斌周斌陈建秋史卫莲任东
Owner YANGTZE RIVER PHARMA GRP JIA NGSU LONGFENGTANG TRADITIONAL CHINESE MEDICINE CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com